Inter-observer variation in the histological diagnosis of polyps in colorectal cancer screening

Histopathology

Volumn 58, Issue 6, 2011, Pages 974-981

  Van Putten, Paul G ^a   Hol, Lieke ^a   Van Dekken, Herman ^b   Han van Krieken, J ^c   Van Ballegooijen, Marjolein ^d   Kuipers, Ernst J ^a   Van Leerdam, Monique E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Department of Public Health ^*  (Netherlands)

Author keywords

Colorectal cancer screening; Colorectal polyps; Histological diagnosis; Interobserver variation

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COLON POLYP; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL DISEASE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOLOGIST; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADENOMA; AGED; COLONIC POLYPS; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FECES; HUMANS; IMMUNOHISTOCHEMISTRY; MASS SCREENING; MIDDLE AGED; OBSERVER VARIATION; OCCULT BLOOD; SIGMOIDOSCOPY;

EID: 79956160282     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03822.x     Document Type: Article

References (48)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 2007; 18; 581-592.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J. Clin. 2007; 57; 43-66.
3. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J. Clin. 2008; 58; 130-160.
4. Mandel JS, Church TR, Bond JH et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N. Engl. J. Med. 2000; 343; 1603-1607.
5. Lieberman DA, Weiss DG, Harford WV et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007; 133; 1077-1085.
6. Laiyemo AO, Murphy G, Sansbury LB et al. Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial. Clin. Gastroenterol. Hepatol. 2009; 7; 192-197.
7. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP. Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am. J. Clin. Pathol. 2005; 124; 380-391.
8. Winawer SJ, Zauber AG, Fletcher RH et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006; 130; 1872-1885.
9. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J. Clin. 2008; 58; 130-160.
10. Bastos J, Peleteiro B, Gouveia J, Coleman MP, Lunet N. The state of the art of cancer control in 30 European countries in 2008. Int. J. Cancer 2009; 126; 2700-2715.
11. Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int. J. Cancer 2008; 122; 1357-1367.
12. Costantini M, Sciallero S, Giannini A et al. Inter-observer agreement in the histologic diagnosis of colorectal polyps. The experience of the multicenter adenoma colorectal study (SMAC). J. Clin. Epidemiol. 2003; 56; 209-214.
13. Yoon H, Martin A, Benamouzig R, Longchampt E, Deyra J, Chaussade S. Inter-observer agreement on histological diagnosis of colorectal polyps: the APACC study. Gastroenterol. Clin. Biol. 2002; 26; 220-224.
14. Hol L, van Leerdam ME, van Ballegooijen M et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical fecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59; 62-68.
15. Jass JR, Sobin LH. Histological typing of intestinal tumours. WHO international histological classification of tumours, 2nd edn. New York: Springer, 1989; 29-40.
16. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 1993; 329; 1977-1981.
17. Atkin WS, Cook CF, Cuzick J et al. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002; 359; 1291-1300.
18. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N. Engl. J. Med. 2000; 343; 162-168.
19. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N. Engl. J. Med. 2001; 345; 555-560.
20. Regula J, Rupinski M, Kraszewska E et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N. Engl. J. Med. 2006; 355; 1863-1872.
21. Schoenfeld P, Cash B, Flood A et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N. Engl. J. Med. 2005; 352; 2061-2068.
22. Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. World Health Organization classification of tumours. Lyon: IARC Press, 2000.
23. Sobin LH, Fleming ID. TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80; 1803-1804.
24. Schlemper RJ, Kato Y, Stolte M. Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J. Gastroenterol. 2001; 36; 445-456.
25. Schlemper RJ, Riddell RH, Kato Y et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47; 251-255.
26. Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys. Ther. 2005; 85; 257-268.
27. Cross SS, Betmouni S, Burton JL et al. What levels of agreement can be expected between histopathologists assigning cases to discrete nominal categories? A study of the diagnosis of hyperplastic and adenomatous colorectal polyps Mod. Pathol. 2000; 13; 941-944.
28. Demers RY, Neale AV, Budev H, Schade WJ. Pathologist agreement in the interpretation of colorectal polyps. Am. J. Gastroenterol. 1990; 85; 417-421.
29. Jensen P, Krogsgaard MR, Christiansen J, Braendstrup O, Johansen A, Olsen J. Observer variability in the assessment of type and dysplasia of colorectal adenomas, analyzed using kappa statistics. Dis. Colon Rectum 1995; 38; 195-198.
30. Rex DK, Alikhan M, Cummings O, Ulbright TM. Accuracy of pathologic interpretation of colorectal polyps by general pathologists in community practice. Gastrointest. Endosc. 1999; 50; 468-474.
31. Terry MB, Neugut AI, Bostick RM, Potter JD, Haile RW, Fenoglio-Preiser CM. Reliability in the classification of advanced colorectal adenomas. Cancer Epidemiol. Biomarkers Prev. 2002; 11; 660-663.
32. Denis B, Peters C, Chapelain C et al. Diagnostic accuracy of community pathologists in the interpretation of colorectal polyps. Eur. J. Gastroenterol. Hepatol. 2009; 21; 1153-1160.
33. Kerkhof M, van Dekken H, Steyerberg EW et al. Grading of dysplasia in Barrett's oesophagus: substantial inter-observer variation between general and gastrointestinal pathologists. Histopathology 2007; 50; 920-927.
34. Eaden J, Abrams K, McKay H, Denley H, Mayberry J. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J. Pathol. 2001; 194; 152-157.
35. McCluggage WG, Walsh MY, Thornton CM et al. Inter- and intra-observer variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system. Br. J. Obstet. Gynaecol. 1998; 105; 206-210.
36. Hassan C, Pickhardt PJ, Kim DH et al. Systematic review: distribution of advanced neoplasia according to polyp size at screening colonoscopy. Aliment. Pharmacol. Ther. 2010; 31; 210-217.
37. Lieberman DA, Holub J, Eisen G, Kraemer D, Morris CD. Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest. Endosc. 2005; 62; 875-883.
38. Brown ML, Klabunde CN, Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am. J. Med. 2003; 115; 129-133.
39. Lau A, Gregor JC. Resource implications for a population-based colorectal cancer screening program in Canada: a study of the impact on colonoscopy capacity and costs in London, Ontario. Can. J. Gastroenterol. 2007; 21; 371-377.
40. Seeff LC, Manninen DL, Dong FB et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology 2004; 127; 1661-1669.
41. Tappenden P, Chilcott J, Eggington S, Patnick J, Sakai H, Karnon J. Option appraisal of population-based colorectal cancer screening programs in England. Gut 2007; 56; 677-684.
42. Vijan S, Inadomi J, Hayward RA, Hofer TP, Fendrick AM. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment. Pharmacol. Ther. 2004; 20; 507-515.
43. Weller D, Coleman D, Robertson R et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br. J. Cancer 2007; 97; 1601-1605.
44. Laiyemo AO, Murphy G, Albert PS et al. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4years. Ann. Intern. Med. 2008; 148; 419-426.
45. Robertson DJ, Burke CA, Welch HG et al. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann. Intern. Med. 2009; 151; 103-109.
46. Martinez ME, Baron JA, Lieberman DA et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2009; 136; 832-841.
47. Nagengast FM, Kaandorp CJ. Revised CBO guideline 'Follow-up after polypectomy'. Nederlands Tijdschrift Geneeskunde 2001; 145; 2022-2025.
48. Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 2002; 51(Suppl. 5); V6-V9.